Abstract:ABSTRACT Portal vein tumor thrombosis (PVTT) frequently leads to malignant ascites (MA) in individuals with hepatocellular carcinoma (HCC), remaining a bottleneck in the treatment. This study aimed to explore the differences in microbes in paired groups and provide novel insights into PVTT and MA-related treatments. Formalin-fixed paraffin embedding ascite samples were collected from MA secondary to HCC and benign ascites (BA) secondary to liver cirrhosis (LC). Ascitic microbiota profiles were determined in the HCC and LC groups by 16S rRNA sequencing. Prognostic risk factors were screened using survival analysis. The correlation between the significantly different microbial signatures in the groups with PVTT (WVT) and non-PVTT (NVT) and clinical characteristics was explored. The expression of different immune cells was determined by labeling four markers in the MA tissue chips using multiplex immunohistochemistry. A total of 240 patients (196 with HCC with MA and 44 with LC with BA) were included in this study. Microbial profiles differed between the HCC and LC groups. PVTT and Barcelona Clinic Liver Cancer stage were shown to be prognostic risk factors. Significant differences in the alpha and beta diversities were observed between the WVT and NVT groups. Gammaproteobacteria and Acinetobacter were the most abundant in the HCC MA. Differences in microbial signatures between the WVT and NVT groups were correlated with the level of C-reactive protein and apolipoprotein A1. This study revealed the microbial differences in the tumor microenvironment of MA secondary to HCC and BA secondary to LC. IMPORTANCE First, we explored the alteration of the ascites ecosystem through the microbiota in patients with hepatocellular carcinoma (HCC) and liver cirrhosis. Second, this is the first clinical study to investigate the differences between patients with HCC with and without portal vein tumor thrombosis via 16S rRNA sequencing. These results revealed a decreased microbial diversity and metabolic dysregulation in individuals with HCC and portal vein tumor thrombosis. Gammaproteobacteria and Acinetobacter were the most abundant in the HCC malignant ascitic fluid. Our study provides a new perspective on treating malignant ascites secondary to HCC.

Ascitic Bacterial Composition is Associated with Clinical Outcomes in Cirrhotic Patients with Culture-Negative and Nonneutrocytic Ascites

Influence of Antibiotic Treatment to the Detection of Ascltes Bacteria by 16S Rrna Microarray

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis.

Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study

Epidemiological Investigation of Non-Fermentative Bacterial Infection in Cirrhotic Patients.

Characterization of the Circulating Microbiome in Acute-on-chronic Liver Failure Associated with Hepatitis B.

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Clinical Significance of Bacterial Dna in Ascites of Patients with Cirrhosis

Application of Next-Generation Sequencing to Study Ascitic Microbiome in Cirrhotic Patients with or Without Spontaneous Bacterial Peritonitis.

Ascitic Microbiota Alteration is Associated with Portal Vein Tumor Thrombosis Occurrence and Prognosis in Hepatocellular Carcinoma

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

IDDF2024-ABS-0186 Analysis of the Correlation Between Gut Microbiota and Disease Severity in Patients with Primary Biliary Cholangitis

Gut Microbiota and Cytokine Profile in Cirrhosis

Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection

Pathogen Profile and Drug Resistance Analysis of Spontaneous Peritonitis in Cirrhotic Patients

Characteristics of Three Microbial Colonization States in the Duodenum of the Cirrhotic Patients.

Community- or Healthcare-Associated Bacterial Infections Increase Long-Term Mortality in Patients With Acute Decompensation of Cirrhosis.

A Metabolomic Analysis of Cirrhotic Ascites

Next- and Third-Generation Sequencing Outperforms Culture-Based Methods in the Diagnosis of Ascitic Fluid Bacterial Infections of ICU Patients

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study